CL2008002880A1 - (s)-2-amino-3-(4-(2-amino-6-((r-1-(4-cloro-2-(3-metil-1h-pirazol-1-il)fenil)-2,2,2-trifluoroetoxi)pirimidin-4-il)fenil)propanoato de etilo cristalino, sal hipurato y succionato del mismo; metodos de preparacion; forma de dosificacion farmaceutica; y uso para tratar sindrome carcinoide y trastorno gastrointestinal. - Google Patents

(s)-2-amino-3-(4-(2-amino-6-((r-1-(4-cloro-2-(3-metil-1h-pirazol-1-il)fenil)-2,2,2-trifluoroetoxi)pirimidin-4-il)fenil)propanoato de etilo cristalino, sal hipurato y succionato del mismo; metodos de preparacion; forma de dosificacion farmaceutica; y uso para tratar sindrome carcinoide y trastorno gastrointestinal.

Info

Publication number
CL2008002880A1
CL2008002880A1 CL2008002880A CL2008002880A CL2008002880A1 CL 2008002880 A1 CL2008002880 A1 CL 2008002880A1 CL 2008002880 A CL2008002880 A CL 2008002880A CL 2008002880 A CL2008002880 A CL 2008002880A CL 2008002880 A1 CL2008002880 A1 CL 2008002880A1
Authority
CL
Chile
Prior art keywords
phenyl
amino
pyrimidin
succinate
chloro
Prior art date
Application number
CL2008002880A
Other languages
English (en)
Inventor
Mark S Bednarz
Paul Susan Margaret De
Ramanaiah Kanamarlapudi
Anett Perlberg
Haiming Zhang
Original Assignee
Lexicon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39944300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008002880(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lexicon Pharmaceuticals Inc filed Critical Lexicon Pharmaceuticals Inc
Publication of CL2008002880A1 publication Critical patent/CL2008002880A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

(S)-2-AM INO-3-(4-(2-AMINO-6-((R)-1-(4-CLORO-2-(3-METIL-1 H-PIRAZOL-1-IL)FENIL)-2,2,2-TRIFLUOROETOXI)PIRIMIDIN-4-IL)FENIL)PROPANOATO DE ETILO CRISTALINO, SAL HIPURATO Y SUCCINATO DEL MISMO; MÉTODOS DE PREPARACIÓN; FORMA DE DOSIFICACIÓN FARMACÉUTICA, Y SU USO PARA TRATAR PREVENIR O GESTIONAR UNA ENFERMEDAD O UN TRASTORNO MEDIADO POR SEROTONINA PERIFÉRICA , DONDE EL TRASTORNO O ENFERMEDAD COMPRENDE SÍNDROME CARCINOIDE, TRASTORNO GASTROINTESTINAL O SÍNDROME DEL INTESTINO IRRITABLE.
CL2008002880A 2007-09-28 2008-09-26 (s)-2-amino-3-(4-(2-amino-6-((r-1-(4-cloro-2-(3-metil-1h-pirazol-1-il)fenil)-2,2,2-trifluoroetoxi)pirimidin-4-il)fenil)propanoato de etilo cristalino, sal hipurato y succionato del mismo; metodos de preparacion; forma de dosificacion farmaceutica; y uso para tratar sindrome carcinoide y trastorno gastrointestinal. CL2008002880A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97584607P 2007-09-28 2007-09-28

Publications (1)

Publication Number Publication Date
CL2008002880A1 true CL2008002880A1 (es) 2009-03-27

Family

ID=39944300

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008002880A CL2008002880A1 (es) 2007-09-28 2008-09-26 (s)-2-amino-3-(4-(2-amino-6-((r-1-(4-cloro-2-(3-metil-1h-pirazol-1-il)fenil)-2,2,2-trifluoroetoxi)pirimidin-4-il)fenil)propanoato de etilo cristalino, sal hipurato y succionato del mismo; metodos de preparacion; forma de dosificacion farmaceutica; y uso para tratar sindrome carcinoide y trastorno gastrointestinal.

Country Status (25)

Country Link
US (2) US8193204B2 (es)
EP (1) EP2203444B1 (es)
JP (1) JP5717445B2 (es)
KR (1) KR101644657B1 (es)
CN (1) CN101809018B (es)
AR (1) AR068558A1 (es)
AU (1) AU2008304439B2 (es)
BR (1) BRPI0817270B1 (es)
CA (1) CA2700835C (es)
CL (1) CL2008002880A1 (es)
CO (1) CO6270325A2 (es)
DK (1) DK2203444T3 (es)
EA (1) EA017275B1 (es)
EC (1) ECSP10010076A (es)
ES (1) ES2431928T3 (es)
IL (1) IL204373A (es)
MX (1) MX2010003326A (es)
NZ (1) NZ583808A (es)
PE (1) PE20090742A1 (es)
PL (1) PL2203444T3 (es)
PT (1) PT2203444E (es)
TW (1) TWI439457B (es)
UA (1) UA102079C2 (es)
UY (1) UY31364A1 (es)
WO (1) WO2009042733A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA019879B1 (ru) 2005-12-29 2014-07-30 Лексикон Фармасьютикалз, Инк. Полициклические производные аминокислот, содержащая их фармацевтическая композиция и способ лечения, использующий эти производные
US7855291B2 (en) * 2005-12-29 2010-12-21 Lexicon Pharmaceuticals, Inc. Process for the preparation of substituted phenylalanines
US7897763B2 (en) 2005-12-29 2011-03-01 Lexicon Pharmaceuticals, Inc. Process for the preparation of substituted phenylalanines
UA99270C2 (en) * 2006-12-12 2012-08-10 Лексикон Фармасьютикалз, Инк. 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
AU2008268409B2 (en) * 2007-06-26 2013-12-05 Lexicon Pharmaceuticals, Inc. Compositions comprising tryptophan hydroxylase inhibitors
AU2008293679B2 (en) * 2007-08-24 2013-09-12 Tersera Therapeutics Llc Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
US8759364B2 (en) * 2008-03-31 2014-06-24 The Trustees Of Columbia University In The City Of New York Methods of treating bone mass diseases
JP2013510092A (ja) * 2009-11-05 2013-03-21 レクシコン ファーマシューティカルズ インコーポレイテッド がんの治療のためのトリプトファンヒドロキシラーゼ阻害剤
TW201302754A (zh) * 2010-11-05 2013-01-16 Lexicon Pharmaceuticals Inc ３－（４－（胺甲基）－１－（５－甲基－７ｈ－吡咯［２，３－ｄ］嘧啶－４－基）哌啶－４－甲醯胺基）苯基二甲基胺基甲酸酯之固態形式
SG11201401583YA (en) * 2011-10-17 2014-09-26 Lexicon Pharmaceuticals Inc Solid dosage forms of (s)-ethyl 2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate
EP3061761A1 (en) 2015-02-24 2016-08-31 Max-Delbrück-Centrum für Molekulare Medizin Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same
EP3275885A1 (en) 2016-07-28 2018-01-31 Max-Delbrück-Centrum für Molekulare Medizin Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same
EP3363798A1 (en) 2017-02-20 2018-08-22 Esteve Química, S.A. Amorphous form of telotristat etiprate
CN109180650A (zh) * 2018-08-28 2019-01-11 湖南华腾制药有限公司 一种氘代色氨酸羟化酶抑制剂的晶型
CA3254893A1 (en) 2022-04-01 2023-10-05 Tersera Therapeutics Llc METHODS FOR REDUCING THE PROBABILITY OF CARCINOID HEART DISEASE IN PATIENTS WITH NEUROENDOCRINE TUMORS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA019879B1 (ru) * 2005-12-29 2014-07-30 Лексикон Фармасьютикалз, Инк. Полициклические производные аминокислот, содержащая их фармацевтическая композиция и способ лечения, использующий эти производные
UA99270C2 (en) * 2006-12-12 2012-08-10 Лексикон Фармасьютикалз, Инк. 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
AU2008293679B2 (en) * 2007-08-24 2013-09-12 Tersera Therapeutics Llc Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
TW200932729A (en) 2007-10-08 2009-08-01 Lexicon Pharmaceuticals Inc Solid forms of (S)-2-amino-3-(4-(2-amino-6-((R)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid and methods of their use

Also Published As

Publication number Publication date
NZ583808A (en) 2012-01-12
TW200922934A (en) 2009-06-01
JP2010540551A (ja) 2010-12-24
WO2009042733A1 (en) 2009-04-02
US8193204B2 (en) 2012-06-05
HK1145023A1 (en) 2011-03-25
UA102079C2 (en) 2013-06-10
MX2010003326A (es) 2010-04-09
IL204373A (en) 2013-12-31
EP2203444B1 (en) 2013-07-24
KR101644657B1 (ko) 2016-08-01
AU2008304439A1 (en) 2009-04-02
BRPI0817270A2 (pt) 2017-06-06
ES2431928T3 (es) 2013-11-28
US8653094B2 (en) 2014-02-18
PL2203444T3 (pl) 2013-12-31
EA017275B1 (ru) 2012-11-30
PE20090742A1 (es) 2009-07-08
AU2008304439B2 (en) 2013-10-17
EP2203444A1 (en) 2010-07-07
US20130005754A1 (en) 2013-01-03
JP5717445B2 (ja) 2015-05-13
AR068558A1 (es) 2009-11-18
ECSP10010076A (es) 2010-04-30
CN101809018A (zh) 2010-08-18
KR20100063736A (ko) 2010-06-11
EA201070410A1 (ru) 2010-10-29
CA2700835A1 (en) 2009-04-02
BRPI0817270B1 (pt) 2022-02-08
US20090088447A1 (en) 2009-04-02
PT2203444E (pt) 2013-09-12
CN101809018B (zh) 2013-02-06
UY31364A1 (es) 2009-03-02
TWI439457B (zh) 2014-06-01
CO6270325A2 (es) 2011-04-20
DK2203444T3 (da) 2013-10-28
CA2700835C (en) 2018-01-09

Similar Documents

Publication Publication Date Title
CL2011002955A1 (es) Compuestos derivados de 3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]octanonitrilo o heptanonitrilo o sus sales, como inhibidores de jak; procedimiento de preparacion; composicion farmaceutica que los comprende; utiles para el tratamiento de trastornos autoinmunes, cancer, entre otras enfermedades.
CL2013003051A1 (es) Compuestos derivados de pirazolo (4.3-d) pirimidinas, inhibidores de quinasa; composicion farmaceutica; y uso para el tratamiento de enfermedades y trastornos del aparato respiratorio
CL2013001723A1 (es) Formas cristalinas de 5-cloro-n2-(2-isopropoxi-5-metil-4-piperidin-4-il-fenil)-n4-[2-(propan-2-sulfonil)-fenil]-pirimidin-2,4-diamina; metodos de preparacion; composicion farmaceutica; y el uso en el tratamiento de los trastornos mediados por la cinasa de linfoma anaplasico.
CA2925624C (en) Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
PE20221914A1 (es) Compuestos de benzaldehido sustituidos y metodos para su uso en incrementar la oxigenacion del tejido
CL2019002900A1 (es) Análogos de benzoazepina como agentes inhibidores de la tirosina cinasa de bruton.
ECSP109934A (es) Compuesto - 946
RU2021102805A (ru) 4,6-ЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-a]ПИРАЗИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-КИНАЗЫ
CL2012000917A1 (es) Compuestos derivados de pirazolo [3,4-d] pirimidina, inhibidores btk; y uso en el tratamiento del cancer, enfermedades autoinmune, mastocitosis,osteoporosis,entre otras.
CL2007003756A1 (es) Compuestos derivados de pirazolo-quinazolina sustituidos, moduladores de la actividad de proteina quinasas; proceso de preparacion; composicion farmaceutica; y uso para el tratamiento del cancer.
PH12015501955A1 (en) Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
CR20130629A (es) Compuestos de 2-(2,4,5-anilino sustituido)pirimidina
MY192354A (en) 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors
ECSP088973A (es) Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3)
CL2008002243A1 (es) Compuestos derivados de 2-pirazolamino-1,3,5-triazina, inhibidores de kinasa jak; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento del cancer.
AR124688A2 (es) Una pirimidina sulfonamida o un tautómero del mismo, o una sal farmacéuticamente aceptable del mismo
PE20090742A1 (es) Formas solidas de (s)-2-amino-3-(4-(2-amino-6-((r)-1-(4-cloro-2-(3-metil-1h-pirazol-1-il)fenil)-2,2,2-trifluoroetoxi)-pirimidin-4-il)fenil)propanoato de etilo y metodos para su uso
UY32190A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibdores de quinasas dependientes de ciclina (cdk), produccion y uso de los mismos como productos medicinales
CL2014001309A1 (es) Compuestos derivados de [1,2,3] triazolo [4,5-d]-pirimidina, agonistas del receptor de canabinoides 2; proceso de obtencion; composicion farmaceutica; uso para el tratamiento o la profilaxis del dolor, aterosclerosis,retinopatia diabetica, diabetes, fibrosis hepatica, fallo cardiaco, entre otras.
MX2018000945A (es) Compuesto pirimidina de anillo fusionado, intermedio y metodo de preparacion, composicion y uso del mismo.
IL231958A0 (en) Solid dosage forms of (s)-ethyl-2-amino-3-(4-(2-amino-6(r)-1-(4-chloro-2-(3-methyl-h1-pyrazol-1-yl )-2,2,2-trifluoroethoxy)pyrimidine-4-yl(phenyl)propanoate
NI201000173A (es) Uso de dronedarona o una sal aceptable farmacéuticamente de ésta, para la preparación de un medicamento para regular el nivel de potasio en la sangre.
NZ708802A (en) Pharmaceutical combinations comprising a protein kinase c inhibitor compound and a mitogen activated protein kinase inhibitor compound
WO2012163088A3 (zh) 肾病和心脏病的治疗药物及其用途
CL2009001112A1 (es) Compuestos derivados de cinolin-3-carboxamida, inhibidores de la quinasa csf-1r; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento del cancer.